A number of different studies indicate that melatonin levels may be linked with breast cancer risk. For example, women with breast cancer show lower levels of melatonin than those that do not have this disease. In addition, laboratory studies indicate that low levels of melatonin stimulate the growth of certain breast cancer cells. When melatonin is added to these cells, their growth is halted. For women whose breast cancer is not improving with tamoxifen (a commonly used chemotherapy drug), preliminary studies have shown that the addition of melatonin may actually encourage tumours to regress slightly. However, if you are considering taking melatonin supplements, you should first consult with a healthcare practitioner to design a comprehensive treatment approach suited to your individual needs.

Similar to the findings with breast cancer, studies of men with prostate cancer suggest that melatonin levels are lower, compared to men without this cancer. Laboratory studies have shown that melatonin inhibits the growth of prostate cancer cells. Higher levels of melatonin in prostate cancer patients are associated with longer survival rates.

Two severe side effects of orthodox cancer treatment and cancer are weight loss and malnutrition. Melatonin helps to combat these symptoms.


Share and Enjoy:

Related Posts: